Strategies for surviving the COVID-19 Series B squeeze

Image Credits: Peter Dazeley / Getty Images

A generation of companies now needs to forget what it has learned. The world has changed for everyone, and nowhere is this more true than in fundraising.

I’ve been investing in technology companies for over twenty years, and I’ve seen how venture capitalists respond in bull and bear markets. I’ve supported companies through the downturns that followed the dot-com bubble and the global financial crisis, and witnessed how founders adapt to the new environment. This current pandemic is no different.

A growth company that only a few months ago was shopping for a $20 million, $30 million, or even $40 million Series B, with a choice of potential investors, must now acknowledge that the shelves may well have emptied.

VCs who were assessing potential new deals at the beginning of the year have had to abruptly adjust their focus: Q1 venture activity in Europe was under its 2019 average, and the figures for the coming months are likely to be much worse as the pipeline empties of deals that were already in progress.

The simple reason for this is that VCs are having to rapidly reallocate their two principal assets: time and capital. More time has to be spent stitching together deals for portfolio companies in need of fresh funding, with little support from outside money. As a result, funds will be putting more capital behind their existing companies, reducing the pool for new investments.

Added to those factors is uncertainty about pricing. VCs take their lead on valuation from the public markets, which have plummeted in tech, as elsewhere. The SEG index of listed SaaS stocks was down 26% year-to-date as of late March. With more pain likely ahead, few investors are going to commit to valuations that founders will accept until there is more certainty that the worst is behind us. A gap will open between newly cautious investors and founders unwilling to bear haircuts up to 50%, dramatic increases in dilution and even the prospect of down rounds. It will likely take quarters — not weeks — for that gulf to be bridged and for many deals to become possible again.

Even in an optimistic scenario, Q2 will largely be a write-off for major new deals and the remainder of the year may only see a gradual recovery. We are probably looking to 2021 before the funding market begins to resemble what it did a few months ago.

In other words, the market for significant new deals is about to become weaker than at any point since the financial crisis of 2008-2009. A generation of companies that has grown up in a benign environment for fundraising now needs to forget what it has learned. There is still a path to growth and success, but it already looks very different from the one that most had plotted.

This is undeniably a challenging time for our community. But as someone who has weathered past downturns, having invested and managed companies through the 2009 and 2001 crises, I know that there is a light at the end of this tunnel.

For companies that find themselves having to reassess their Series B plans, I would offer these pieces of advice.

The next few quarters will be the most challenging time that many founders have experienced. More so than ever, survival is not a given. Our advice as a firm is to remain focused — in the short-term, on making your company as robust as possible, and in the medium-term, on raising the next large round that will reset your course toward category leadership. Don’t lose sight of your destination; just accept that the route has become a little longer.

Latest Stories